Skip to main navigation Skip to search Skip to main content

Adipose tissue and anti-inflammatory pharmacotherapy

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

The hypothesis that low grade chronic systemic inflammation involving adipocytederived factors links obesity to clinical metabolic disorders is attracting growing support. Observational and experimental models of obesity have revealed that significant amounts of pro-inflammatory mediators are synthesized and secreted by adipose tissue. It is hypothesized that the release of pro-inflammatory adipokines and the cessation of synthesis of normally anti-inflammatory mediators may be caused by adipocyte hypertrophy or hyperplasia that promotes local hypoxia and cellular stress (de Luca and Olefsky, 2008).

Original languageEnglish
Title of host publicationAdipose Tissue and Inflammation
PublisherCRC Press
Pages285-296
Number of pages12
ISBN (Electronic)9781420091311
ISBN (Print)9781420091304
DOIs
StatePublished - Jan 1 2009

Fingerprint

Dive into the research topics of 'Adipose tissue and anti-inflammatory pharmacotherapy'. Together they form a unique fingerprint.

Cite this